In a 78-year-old woman with mild postmenopausal bleeding and ultrasound findings suggestive of adenomyosis, what is the appropriate diagnostic and management approach?

Postmenopausal Bleeding with Adenomyosis: Proceed with Endometrial Tissue Sampling

In a 78-year-old woman with postmenopausal bleeding, the adenomyosis finding is a red herring—you must exclude endometrial cancer through endometrial tissue sampling, regardless of the adenomyosis. The ultrasound should have reported endometrial thickness, and this measurement determines your next step.

Critical First Step: Assess Endometrial Thickness

The transvaginal ultrasound report must include endometrial thickness measurement 1:

• If endometrial thickness ≥5 mm: Proceed immediately to endometrial tissue sampling (office endometrial biopsy or D&C)
• If endometrial thickness <4 mm: The negative predictive value for cancer is nearly 100%, but given she has active bleeding, tissue sampling is still warranted 1

The adenomyosis is irrelevant to the immediate workup—postmenopausal bleeding demands exclusion of endometrial malignancy first 2.

Why Adenomyosis Doesn't Change Your Approach

While adenomyosis can cause abnormal bleeding, it is:

• Extremely rare in postmenopausal women 3
• A diagnosis of exclusion after cancer is ruled out
• Cannot be assumed as the cause of bleeding without tissue diagnosis 2

Adenomyosis in a 78-year-old is so unusual that one recent case report described it as a "postmenopausal diagnostic perplexity" that mimicked invasive neoplasm 3. This underscores why you cannot attribute bleeding to adenomyosis without first excluding malignancy.

Diagnostic Algorithm

Step 1: Endometrial Tissue Sampling

Perform office endometrial biopsy 2:

• False-negative rate is approximately 10%
• If negative but bleeding persists → proceed to fractional D&C under anesthesia
• Hysteroscopy may be added if a focal lesion (polyp) is suspected 2

Step 2: If Initial Sampling is Inadequate or Inconclusive

Consider additional imaging 1:

• Saline infusion sonohysterography: Can distinguish focal lesions (polyps vs. submucosal fibroids) but cannot reliably differentiate benign from malignant pathology 1
• MRI pelvis with contrast and diffusion-weighted imaging: Superior for visualizing the endometrium when ultrasound is limited, can identify malignant features with sensitivity up to 79% and specificity up to 89% 1

Step 3: Repeat Tissue Sampling if Needed

If initial biopsy is negative but clinical suspicion remains high (persistent bleeding, thickened endometrium), repeat sampling or proceed to D&C 1. Endometrial cancers can be missed on initial sampling 1.

Common Pitfalls to Avoid

1. Attributing bleeding to adenomyosis without tissue diagnosis: This is the most dangerous error—approximately 90% of endometrial cancer patients present with postmenopausal bleeding 2

2. Relying solely on imaging: Ultrasound and even MRI cannot reliably distinguish benign from malignant endometrial pathology 1. Tissue is the issue.

3. Accepting a single negative biopsy in persistent bleeding: The 10% false-negative rate mandates repeat sampling or D&C if bleeding continues 2

4. Assuming adenomyosis explains the clinical picture: Adenomyosis is predominantly a disease of reproductive-aged women; its presence in a 78-year-old is highly atypical and should not distract from cancer exclusion 3, 4, 5

If Endometrial Pathology is Benign

Only after malignancy is excluded can you address the adenomyosis, though management options are limited at age 78:

• Most medical therapies (hormonal suppression, levonorgestrel IUD) are designed for reproductive-aged women 6, 5
• Hysterectomy remains definitive if bleeding is severe and impacts quality of life 4, 5
• Conservative management may be appropriate if bleeding is truly mild and tissue diagnosis is benign

The bottom line: Postmenopausal bleeding is endometrial cancer until proven otherwise—obtain tissue diagnosis immediately 1, 2.